Picture of Swedish Orphan Biovitrum AB (publ) logo

SOBI — Swedish Orphan Biovitrum AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: SOBI Says Co To Acquire Arthrosi Therapeutics For $1.5 billion

Dec 13 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

SOBI TO ACQUIRE ARTHROSI THERAPEUTICS, STRENGTHENING PIPELINE FOR THE POTENTIAL TREATMENT OF GOUT

SWEDISH ORPHAN BIOVITRUM - SOBI TO PAY $950 MILLION UPFRONT FOR ARTHROSI

SWEDISH ORPHAN BIOVITRUM - ACQUISITION EXPECTED TO BE HIGHLY ACCRETIVE TO SOBI'S MID- TO LONG-TERM GROWTH AND MARGIN TRAJECTORY

SWEDISH ORPHAN BIOVITRUM - SOBI TO PAY UP TO $550 MILLION IN MILESTONES

Source text: ID:nWkr8hWRtK

Further company coverage: SOBIV.ST

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Swedish Orphan Biovitrum AB (publ)

See all news